Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 22, 2017 08:30 ET | Source: Amyris

Amyris Exceeds Previous Debt Reduction Goal of $75 Million – $86 Million In Debt Retired

EMERYVILLE, Calif., May 22, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced it has already exceeded the debt reduction goal the company stated...
May 15, 2017 16:21 ET | Source: Amyris

Amyris Reports 164% Product Revenue Growth over Prior Year & Continued Strong Outlook

Q1 2017 revenues of $13.0 million, up 47% over $8.8 million for Q1 2016Q1 2017 product sales of $8.3 million, up 164% over $3.1 million for Q1 2016 with Biossance sales also at a record level powered...
May 11, 2017 15:38 ET | Source: Amyris

Amyris Announces Closing Of First Tranche Of Up To $95 Million In Equity Financing And Conversion Of Over $55 Million Of Debt To Equity

EMERYVILLE, Calif., May 11, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced the closing of the first tranche of up to $95 million in planned...
May 10, 2017 08:30 ET | Source: Amyris

Amyris On-Track To Double Revenue For Vitamin E Partnership With Nenter & Announces Exclusive Vitamin A License With Royal DSM

EMERYVILLE, Calif., May 10, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it expects revenue related to its Vitamin E partnership with...
May 09, 2017 08:30 ET | Source: Amyris

Amyris to Host & Videocast 1st Annual Biotech Summit and Investor Day on Tuesday, May 16, 2017

EMERYVILLE, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) today announced that it will host its 1st Annual Biotech Summit on Tuesday, May 16, 2017 at its headquarters in...
May 09, 2017 08:00 ET | Source: Amyris

Amyris to Announce First Quarter 2017 Financial Results on Monday, May 15, 2017

EMERYVILLE, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the first quarter ended March 31, 2017 after market close on Monday, May 15,...
May 08, 2017 08:30 ET | Source: Amyris; Royal DSM

Royal DSM To Make Equity Investment In Amyris With the Purpose of Establishing a Long-Term Relationship

HEERLEN, Netherlands and EMERYVILLE, Calif., May 08, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, and Koninklijke DSM N.V. (Royal DSM) (AEX:DSM.AS), the...
May 08, 2017 08:30 ET | Source: Amyris

Amyris Announces Agreements For Up to $95 Million In Equity Financing And In-Process Initiative To Significantly Reduce Debt

EMERYVILLE, Calif., May 08, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced a series of agreements for up to $95 million in equity financing...
May 05, 2017 08:00 ET | Source: Amyris

Amyris Announces Much Better Than Expected Sales Of Farnesene To Meet Accelerated Demand For Liquid Farnesene Rubber By Global Tire Brands

EMERYVILLE, Calif., May 05, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that its partner’s success in developing high performance liquid...
May 02, 2017 08:00 ET | Source: Amyris

Amyris Announces Key Advancements Under DARPA Multi-Year Technology Investment Agreement – Enables Development of Industrial-Scale Fermentation Process For Virtually Any Biological Molecule

EMERYVILLE, Calif., May 02, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has successfully expanded its world-class expertise in...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right